Related Experiment Video
Updated: Aug 20, 2026

Targeting Gray Rami Communicantes in Selective Chemical Lumbar Sympathectomy
Published on: January 10, 2019
Effects of Endoscopic Thoracic Sympathectomy on Raynaud's Disease
Sami Karapolat1, Atila Turkyilmaz1, Celal Tekinbas1
1Department of Thoracic Surgery, Karadeniz Technical University Medical School , Trabzon, Turkey .
Introduction:
Raynaud's disease is a disorder that is characterized by attacks of pain, cyanosis, redness, and numbness in the upper extremities caused by vasospasm of digital arteries due to cold or emotional stress. We aimed at demonstrating our experiences with endoscopic thoracic sympathectomy (ETS) in the treatment of Raynaud's disease.
Methods:
From 48 patients who underwent ETS for various reasons at our department between January 2014 and January 2015, we reviewed 9 patients with Raynaud's disease (18.7%) with respect to their demographic characteristics such as gender and age, postoperative complications, short-term results, side effects, recurrence of symptoms, and long-terms results.
Results:
The symptoms and findings reappeared and the number and dosage of the drugs used returned to their preoperative levels in 66.6% of the patients at month 6, and in all patients except 1 at the end of the 1st year.
Conclusion:
ETS should be considered an ultimate choice for patients with Raynaud's disease who have treatment-resistant severe symptoms and serious complications, disturbed social and daily lives, and impaired quality of life, and all patients should be properly informed before the surgery about the possibility of a high rate of recurrence.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Aortic Regurgitation III: Medical Management
Peripheral Artery Disease III: Interprofessional Care

